APO Research
Talk to an analyst

APO RESEARCH · REPORT

Polymyxin B Sulfate

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Polymyxin B Sulfate Market Outlook and Growth Opportunities 2026

30 December 2025197 pages

Choose your research edition.

Industry ResearchPolymyxin B Sulfate Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Polymyxin B Sulfate Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Polymyxin B Sulfate Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Polymyxin B Sulfate Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Polymyxin B Sulfate Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Polymyxin B Sulfate market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Polymyxin B Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Polymyxin B Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Polymyxin B Sulfate is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Polymyxin B Sulfate market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Polymyxin B Sulfate market include AKORN, XELLIA PHARMS APS, SANDOZ INC, FRESENIUS KABI USA, Concord Biotech, BAUSCH AND LOMB, AuroMedics and Allergan, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Polymyxin B Sulfate market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Polymyxin B Sulfate and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Polymyxin B Sulfate sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Polymyxin B Sulfate market size, projected growth trends, production technologies, key applications, and end-use industries.

Polymyxin B Sulfate Segment by Company

AKORN

XELLIA PHARMS APS

SANDOZ INC

FRESENIUS KABI USA

Concord Biotech

BAUSCH AND LOMB

AuroMedics

Allergan

Polymyxin B Sulfate Segment by Type

Tablets

Injections

Polymyxin B Sulfate Segment by Application

Hospitals

Private Clinics

Others

Polymyxin B Sulfate Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Polymyxin B Sulfate status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Polymyxin B Sulfate market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Polymyxin B Sulfate significant trends, drivers, influence factors in global and regions.

6. To analyze Polymyxin B Sulfate competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Polymyxin B Sulfate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Polymyxin B Sulfate and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Polymyxin B Sulfate.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Polymyxin B Sulfate market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Polymyxin B Sulfate industry.

Chapter 3: Detailed analysis of Polymyxin B Sulfate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Polymyxin B Sulfate in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Polymyxin B Sulfate in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Polymyxin B Sulfate Industry Trends Table 2. Polymyxin B Sulfate Industry Drivers Table 3. Polymyxin B Sulfate Industry Opportunities and Challenges Table 4. Polymyxin B Sulfate Industry Restraints Table 5. Global Polymyxin B Sulfate Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Polymyxin B Sulfate Revenue Share by Company (2021-2026) Table 7. Global Polymyxin B Sulfate Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Polymyxin B Sulfate Sales Volume Share by Company (2021-2026) Table 9. Global Polymyxin B Sulfate Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Polymyxin B Sulfate Company Ranking, (2024-2026) & (USD Million) Table 11. Global Polymyxin B Sulfate Key Company Manufacturing Base & Headquarters Table 12. Global Polymyxin B Sulfate Company, Product Type & Application Table 13. Global Polymyxin B Sulfate Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Polymyxin B Sulfate by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Tablets Table 18. Significant Companies of Injections Table 19. Global Polymyxin B Sulfate Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Polymyxin B Sulfate Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Polymyxin B Sulfate Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Polymyxin B Sulfate Sales Volume Share by Type (2021-2026) Table 23. Global Polymyxin B Sulfate Sales Volume Share by Type (2027-2032) Table 24. Global Polymyxin B Sulfate Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Polymyxin B Sulfate Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Polymyxin B Sulfate Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Polymyxin B Sulfate Sales Value Share by Type (2021-2026) Table 28. Global Polymyxin B Sulfate Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospitals Table 30. Significant Companies of Private Clinics Table 31. Significant Companies of Others Table 32. Global Polymyxin B Sulfate Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Polymyxin B Sulfate Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Polymyxin B Sulfate Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Polymyxin B Sulfate Sales Volume Share by Application (2021-2026) Table 36. Global Polymyxin B Sulfate Sales Volume Share by Application (2027-2032) Table 37. Global Polymyxin B Sulfate Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Polymyxin B Sulfate Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Polymyxin B Sulfate Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Polymyxin B Sulfate Sales Value Share by Application (2021-2026) Table 41. Global Polymyxin B Sulfate Sales Value Share by Application (2027-2032) Table 42. Global Polymyxin B Sulfate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Polymyxin B Sulfate Sales by Region (2021-2026) & (K Units) Table 44. Global Polymyxin B Sulfate Sales Market Share by Region (2021-2026) Table 45. Global Polymyxin B Sulfate Sales by Region (2027-2032) & (K Units) Table 46. Global Polymyxin B Sulfate Sales Market Share by Region (2027-2032) Table 47. Global Polymyxin B Sulfate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Polymyxin B Sulfate Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Polymyxin B Sulfate Sales Value Share by Region (2021-2026) Table 50. Global Polymyxin B Sulfate Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Polymyxin B Sulfate Sales Value Share by Region (2027-2032) Table 52. Global Polymyxin B Sulfate Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Polymyxin B Sulfate Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Polymyxin B Sulfate Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Polymyxin B Sulfate Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Polymyxin B Sulfate Sales by Country (2021-2026) & (K Units) Table 57. Global Polymyxin B Sulfate Sales Market Share by Country (2021-2026) Table 58. Global Polymyxin B Sulfate Sales by Country (2027-2032) & (K Units) Table 59. Global Polymyxin B Sulfate Sales Market Share by Country (2027-2032) Table 60. Global Polymyxin B Sulfate Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Polymyxin B Sulfate Sales Value Market Share by Country (2021-2026) Table 62. Global Polymyxin B Sulfate Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Polymyxin B Sulfate Sales Value Market Share by Country (2027-2032) Table 64. AKORN Company Information Table 65. AKORN Business Overview Table 66. AKORN Polymyxin B Sulfate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. AKORN Polymyxin B Sulfate Product Portfolio Table 68. AKORN Recent Development Table 69. XELLIA PHARMS APS Company Information Table 70. XELLIA PHARMS APS Business Overview Table 71. XELLIA PHARMS APS Polymyxin B Sulfate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. XELLIA PHARMS APS Polymyxin B Sulfate Product Portfolio Table 73. XELLIA PHARMS APS Recent Development Table 74. SANDOZ INC Company Information Table 75. SANDOZ INC Business Overview Table 76. SANDOZ INC Polymyxin B Sulfate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. SANDOZ INC Polymyxin B Sulfate Product Portfolio Table 78. SANDOZ INC Recent Development Table 79. FRESENIUS KABI USA Company Information Table 80. FRESENIUS KABI USA Business Overview Table 81. FRESENIUS KABI USA Polymyxin B Sulfate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. FRESENIUS KABI USA Polymyxin B Sulfate Product Portfolio Table 83. FRESENIUS KABI USA Recent Development Table 84. Concord Biotech Company Information Table 85. Concord Biotech Business Overview Table 86. Concord Biotech Polymyxin B Sulfate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Concord Biotech Polymyxin B Sulfate Product Portfolio Table 88. Concord Biotech Recent Development Table 89. BAUSCH AND LOMB Company Information Table 90. BAUSCH AND LOMB Business Overview Table 91. BAUSCH AND LOMB Polymyxin B Sulfate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. BAUSCH AND LOMB Polymyxin B Sulfate Product Portfolio Table 93. BAUSCH AND LOMB Recent Development Table 94. AuroMedics Company Information Table 95. AuroMedics Business Overview Table 96. AuroMedics Polymyxin B Sulfate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. AuroMedics Polymyxin B Sulfate Product Portfolio Table 98. AuroMedics Recent Development Table 99. Allergan Company Information Table 100. Allergan Business Overview Table 101. Allergan Polymyxin B Sulfate Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Allergan Polymyxin B Sulfate Product Portfolio Table 103. Allergan Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Polymyxin B Sulfate Distributors List Table 107. Polymyxin B Sulfate Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Polymyxin B Sulfate Product Image Figure 2. Global Polymyxin B Sulfate Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Polymyxin B Sulfate Sales Value (2021-2032) & (US$ Million) Figure 4. Global Polymyxin B Sulfate Sales (2021-2032) & (K Units) Figure 5. Global Polymyxin B Sulfate Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Polymyxin B Sulfate Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Tablets Image Figure 10. Injections Image Figure 11. Global Polymyxin B Sulfate Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Polymyxin B Sulfate Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Polymyxin B Sulfate Sales Volume Share by Type (2021-2032) Figure 14. Global Polymyxin B Sulfate Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Polymyxin B Sulfate Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Polymyxin B Sulfate Sales Value Share by Type (2021-2032) Figure 17. Hospitals Image Figure 18. Private Clinics Image Figure 19. Others Image Figure 20. Global Polymyxin B Sulfate Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Polymyxin B Sulfate Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Polymyxin B Sulfate Sales Volume Share by Application (2021-2032) Figure 23. Global Polymyxin B Sulfate Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Polymyxin B Sulfate Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Polymyxin B Sulfate Sales Value Share by Application (2021-2032) Figure 26. Global Polymyxin B Sulfate Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Polymyxin B Sulfate Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Polymyxin B Sulfate Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Polymyxin B Sulfate Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Polymyxin B Sulfate Sales Value (2021-2032) & (US$ Million) Figure 31. North America Polymyxin B Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Polymyxin B Sulfate Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Polymyxin B Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Polymyxin B Sulfate Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Polymyxin B Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Polymyxin B Sulfate Sales Value (2021-2032) & (US$ Million) Figure 37. South America Polymyxin B Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Polymyxin B Sulfate Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Polymyxin B Sulfate Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Polymyxin B Sulfate Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Polymyxin B Sulfate Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Polymyxin B Sulfate Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Tablets
  • Injections
Applications
  • Hospitals
  • Private Clinics
  • Others
Companies covered
  • AKORN
  • XELLIA PHARMS APS
  • SANDOZ INC
  • FRESENIUS KABI USA
  • Concord Biotech
  • BAUSCH AND LOMB
  • AuroMedics
  • Allergan

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Polymyxin B Sulfate Sales Value (2021-2032)
  4. 1.2.2 Global Polymyxin B Sulfate Sales Volume (2021-2032)
  5. 1.2.3 Global Polymyxin B Sulfate Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Polymyxin B Sulfate Market Dynamics
  1. 2.1 Polymyxin B Sulfate Industry Trends
  2. 2.2 Polymyxin B Sulfate Industry Drivers
  3. 2.3 Polymyxin B Sulfate Industry Opportunities and Challenges
  4. 2.4 Polymyxin B Sulfate Industry Restraints
3 Polymyxin B Sulfate Market by Company
  1. 3.1 Global Polymyxin B Sulfate Company Revenue Ranking in 2025
  2. 3.2 Global Polymyxin B Sulfate Revenue by Company (2021-2026)
  3. 3.3 Global Polymyxin B Sulfate Sales Volume by Company (2021-2026)
  4. 3.4 Global Polymyxin B Sulfate Average Price by Company (2021-2026)
  5. 3.5 Global Polymyxin B Sulfate Company Ranking (2024-2026)
  6. 3.6 Global Polymyxin B Sulfate Company Manufacturing Base and Headquarters
  7. 3.7 Global Polymyxin B Sulfate Company Product Type and Application
  8. 3.8 Global Polymyxin B Sulfate Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Polymyxin B Sulfate Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Polymyxin B Sulfate Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Polymyxin B Sulfate Market by Type
  1. 4.1 Polymyxin B Sulfate Type Introduction
  2. 4.1.1 Tablets
  3. 4.1.2 Injections
  4. 4.2 Global Polymyxin B Sulfate Sales Volume by Type
  5. 4.2.1 Global Polymyxin B Sulfate Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Polymyxin B Sulfate Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Polymyxin B Sulfate Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Polymyxin B Sulfate Sales Value by Type
  9. 4.3.1 Global Polymyxin B Sulfate Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Polymyxin B Sulfate Sales Value by Type (2021-2032)
  11. 4.3.3 Global Polymyxin B Sulfate Sales Value Share by Type (2021-2032)
5 Polymyxin B Sulfate Market by Application
  1. 5.1 Polymyxin B Sulfate Application Introduction
  2. 5.1.1 Hospitals
  3. 5.1.2 Private Clinics
  4. 5.1.3 Others
  5. 5.2 Global Polymyxin B Sulfate Sales Volume by Application
  6. 5.2.1 Global Polymyxin B Sulfate Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Polymyxin B Sulfate Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Polymyxin B Sulfate Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Polymyxin B Sulfate Sales Value by Application
  10. 5.3.1 Global Polymyxin B Sulfate Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Polymyxin B Sulfate Sales Value by Application (2021-2032)
  12. 5.3.3 Global Polymyxin B Sulfate Sales Value Share by Application (2021-2032)
6 Polymyxin B Sulfate Regional Sales and Value Analysis
  1. 6.1 Global Polymyxin B Sulfate Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Polymyxin B Sulfate Sales by Region (2021-2032)
  3. 6.2.1 Global Polymyxin B Sulfate Sales by Region: 2021-2026
  4. 6.2.2 Global Polymyxin B Sulfate Sales by Region (2027-2032)
  5. 6.3 Global Polymyxin B Sulfate Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Polymyxin B Sulfate Sales Value by Region (2021-2032)
  7. 6.4.1 Global Polymyxin B Sulfate Sales Value by Region: 2021-2026
  8. 6.4.2 Global Polymyxin B Sulfate Sales Value by Region (2027-2032)
  9. 6.5 Global Polymyxin B Sulfate Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Polymyxin B Sulfate Sales Value (2021-2032)
  12. 6.6.2 North America Polymyxin B Sulfate Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Polymyxin B Sulfate Sales Value (2021-2032)
  15. 6.7.2 Europe Polymyxin B Sulfate Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Polymyxin B Sulfate Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Polymyxin B Sulfate Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Polymyxin B Sulfate Sales Value (2021-2032)
  21. 6.9.2 South America Polymyxin B Sulfate Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Polymyxin B Sulfate Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Polymyxin B Sulfate Sales Value Share by Country, 2025 VS 2032
7 Polymyxin B Sulfate Country-level Sales and Value Analysis
  1. 7.1 Global Polymyxin B Sulfate Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Polymyxin B Sulfate Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Polymyxin B Sulfate Sales by Country (2021-2032)
  4. 7.3.1 Global Polymyxin B Sulfate Sales by Country (2021-2026)
  5. 7.3.2 Global Polymyxin B Sulfate Sales by Country (2027-2032)
  6. 7.4 Global Polymyxin B Sulfate Sales Value by Country (2021-2032)
  7. 7.4.1 Global Polymyxin B Sulfate Sales Value by Country (2021-2026)
  8. 7.4.2 Global Polymyxin B Sulfate Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Polymyxin B Sulfate Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Polymyxin B Sulfate Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Polymyxin B Sulfate Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 AKORN
  2. 8.1.1 AKORN Company Information
  3. 8.1.2 AKORN Business Overview
  4. 8.1.3 AKORN Polymyxin B Sulfate Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 AKORN Polymyxin B Sulfate Product Portfolio
  6. 8.1.5 AKORN Recent Developments
  7. 8.2 XELLIA PHARMS APS
  8. 8.2.1 XELLIA PHARMS APS Company Information
  9. 8.2.2 XELLIA PHARMS APS Business Overview
  10. 8.2.3 XELLIA PHARMS APS Polymyxin B Sulfate Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 XELLIA PHARMS APS Polymyxin B Sulfate Product Portfolio
  12. 8.2.5 XELLIA PHARMS APS Recent Developments
  13. 8.3 SANDOZ INC
  14. 8.3.1 SANDOZ INC Company Information
  15. 8.3.2 SANDOZ INC Business Overview
  16. 8.3.3 SANDOZ INC Polymyxin B Sulfate Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 SANDOZ INC Polymyxin B Sulfate Product Portfolio
  18. 8.3.5 SANDOZ INC Recent Developments
  19. 8.4 FRESENIUS KABI USA
  20. 8.4.1 FRESENIUS KABI USA Company Information
  21. 8.4.2 FRESENIUS KABI USA Business Overview
  22. 8.4.3 FRESENIUS KABI USA Polymyxin B Sulfate Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 FRESENIUS KABI USA Polymyxin B Sulfate Product Portfolio
  24. 8.4.5 FRESENIUS KABI USA Recent Developments
  25. 8.5 Concord Biotech
  26. 8.5.1 Concord Biotech Company Information
  27. 8.5.2 Concord Biotech Business Overview
  28. 8.5.3 Concord Biotech Polymyxin B Sulfate Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Concord Biotech Polymyxin B Sulfate Product Portfolio
  30. 8.5.5 Concord Biotech Recent Developments
  31. 8.6 BAUSCH AND LOMB
  32. 8.6.1 BAUSCH AND LOMB Company Information
  33. 8.6.2 BAUSCH AND LOMB Business Overview
  34. 8.6.3 BAUSCH AND LOMB Polymyxin B Sulfate Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BAUSCH AND LOMB Polymyxin B Sulfate Product Portfolio
  36. 8.6.5 BAUSCH AND LOMB Recent Developments
  37. 8.7 AuroMedics
  38. 8.7.1 AuroMedics Company Information
  39. 8.7.2 AuroMedics Business Overview
  40. 8.7.3 AuroMedics Polymyxin B Sulfate Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 AuroMedics Polymyxin B Sulfate Product Portfolio
  42. 8.7.5 AuroMedics Recent Developments
  43. 8.8 Allergan
  44. 8.8.1 Allergan Company Information
  45. 8.8.2 Allergan Business Overview
  46. 8.8.3 Allergan Polymyxin B Sulfate Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Allergan Polymyxin B Sulfate Product Portfolio
  48. 8.8.5 Allergan Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Polymyxin B Sulfate Value Chain Analysis
  2. 9.1.1 Polymyxin B Sulfate Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Polymyxin B Sulfate Sales Mode & Process
  6. 9.2 Polymyxin B Sulfate Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Polymyxin B Sulfate Distributors
  9. 9.2.3 Polymyxin B Sulfate Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst